Prins, J.M.

patient study therapy concentration plasma group treatment infection month women viremia antibiotic antiretroviral stroke resistance antiretroviral therapy baseline tmp-smx prophylaxi cranberry haart dose reduction netherland episode follow-up count center analysis trial nvp plasma concentrations level pregnancy 12 months hbv dna effect reduction result tract number discontinuation virologic signi t-cell measurement amsterdam disease event hepatitis response outcome interruption hepatocellular carcinoma table plasma concentrations virologic response department virus control erasmus mc efavirenz e coli change tract infections association treatment interruption score william virological lippincott wilkin cranberry group african descent efv plasma concentration acquir randomized urine syndr signi ficantly ef ficacy prophylaxis use